The liver is one of the major targets for insulin and its counterregulatory hormones, such as glucagon. Overall, glucose intolerance has been seen in up to 80% of patients with CLD, and frank diabetes is present in 30–60%. Chronic liver disease (CLD) is often associated with glucose intolerance and diabetes because of the presence of insulin resistance and β-cell dysfunction. In this video, lets us have a closer look at the relationship between diabetes and chronic liver disease.
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article